Objective: Autoantibodies cross-reacting with the β1 adrenergic receptor (anti-β1AR and anti-p2β) and cardiac myosin antigens (anti-B13) have been related to the pathogenesis of chronic Chagas heart disease (CCHD). Studies exploring their levels in different stages are scarce. We aimed to evaluate the relationship of these autoantibodies with the clinical profile of chronic patients, especially regarding their classificatory accuracy in severe presentation with heart failure. Methods and results: We conducted a cross-sectional study of 155 T. cruzi-seropositive patients and 26 age- and gender-matched healthy controls. They were categorised in three stages of CCHD. Serum antibodies were measured by specific immunoassays. Symptomatic individu...
Rationale: Autoantibodies directed against the second extracellular loop of the cardiac 1-adrenergic...
Chronic Chagas heart disease (cChHD), a chronic manifestation of the Trypanosoma cruzi infection, is...
Chagas disease continues to be a significant public health problem, as ca. 10 million people are sti...
Introduction and objectives Trypanosoma cruzi infection has been shown to induce humoral autoimmune...
Chronic chagasic cardiomyopathy (CCC) is characterized mainly by a dilated cardiomyopathy complicate...
Chagas disease is one of the most important endemic infections in Latin America affecting around 6-7...
Background Studies indicate that antibodies cross-reacting with cardiac β1 adrenergic receptors are ...
Introduction: chronic Chagas heart disease (CCHD) is the most common manifestation of American Trypa...
<p>(A) Inverse of the anti-<i>T</i>. <i>cruzi</i> IgG<sub>3</sub> titers in sera of patients with ch...
Introduction. Chagas´ disease is the main cause of chronic myocardiopathy in Central America. ...
<p>(A) Inverse of the anti-<i>T</i>. <i>cruzi</i> IgG<sub>1</sub> titers in sera of patients with ch...
<p>(A) Inverse of the anti-<i>T</i>. <i>cruzi</i> IgG<sub>2</sub> titers in sera of patients with ch...
Studies indicate that Trypanosoma cruzi is capable of inducing immunological disturbances such as de...
ObjectivesDistinguishing the patterns of autoantibodies (AAB) against G-protein–coupled receptors in...
We investigated the relationship between potentially pathogenic antibodies against a Trypanosoma cru...
Rationale: Autoantibodies directed against the second extracellular loop of the cardiac 1-adrenergic...
Chronic Chagas heart disease (cChHD), a chronic manifestation of the Trypanosoma cruzi infection, is...
Chagas disease continues to be a significant public health problem, as ca. 10 million people are sti...
Introduction and objectives Trypanosoma cruzi infection has been shown to induce humoral autoimmune...
Chronic chagasic cardiomyopathy (CCC) is characterized mainly by a dilated cardiomyopathy complicate...
Chagas disease is one of the most important endemic infections in Latin America affecting around 6-7...
Background Studies indicate that antibodies cross-reacting with cardiac β1 adrenergic receptors are ...
Introduction: chronic Chagas heart disease (CCHD) is the most common manifestation of American Trypa...
<p>(A) Inverse of the anti-<i>T</i>. <i>cruzi</i> IgG<sub>3</sub> titers in sera of patients with ch...
Introduction. Chagas´ disease is the main cause of chronic myocardiopathy in Central America. ...
<p>(A) Inverse of the anti-<i>T</i>. <i>cruzi</i> IgG<sub>1</sub> titers in sera of patients with ch...
<p>(A) Inverse of the anti-<i>T</i>. <i>cruzi</i> IgG<sub>2</sub> titers in sera of patients with ch...
Studies indicate that Trypanosoma cruzi is capable of inducing immunological disturbances such as de...
ObjectivesDistinguishing the patterns of autoantibodies (AAB) against G-protein–coupled receptors in...
We investigated the relationship between potentially pathogenic antibodies against a Trypanosoma cru...
Rationale: Autoantibodies directed against the second extracellular loop of the cardiac 1-adrenergic...
Chronic Chagas heart disease (cChHD), a chronic manifestation of the Trypanosoma cruzi infection, is...
Chagas disease continues to be a significant public health problem, as ca. 10 million people are sti...